Toripalimab With Chemotherapy for Sinus Cancer

Clinical trial NCT06940180 · RECRUITING

Trial details

NCT number: NCT06940180
Sponsor: Glenn J. Hanna
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Sinonasal Cancer Paranasal Sinus Neoplasms Squamous Cell Carcinoma Sinonasal Undifferentiated Carcinoma Locally Advanced Head and Neck Cancer

Start date: 2025-06-17
Primary completion: 2028-02-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.